Patent details

Basic Information

Publication number:

EP3763742

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP201914207

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS

French Title of Invention:

CONJUGUÉS ANTI-PD-L1 POUR LE TRAITEMENT DES TUMEURS

German Title of Invention:

ANTI-PD-L1-KONJUGATE ZUR BEHANDLUNG VON TUMOREN

SPC Number:

Dates

Filing date:

29/08/2015

Grant date:

05/10/2022

EP Publication Date:

13/01/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/10/2022

EP B1 Publication Date:

05/10/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/08/2023

Expiration date:

29/08/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/09/2022

 

 

Name:

Birdie Biopharmaceuticals Inc.

Address:

Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay, Grand Cayman, Cayman Islands (KY)

Inventor

1

Name:

LAU, Walter

Address:

China (CN)

2

Name:

LI, Lixin

Address:

China (CN)

Priority

Priority Number:

201410440824

Priority Date:

01/09/2014

Priority Country:

China (CN)

Classification

IPC classification:

C07K 16/30; A61K 31/4745; A61K 31/708; A61K 31/4375; A61K 47/50; A61K 45/00; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202240

Publication date:

05/10/2022

Description:

Grant (B1)

2

Issue number:

202245

Publication date:

09/11/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages